Is increased serum S-100 protein concentration a marker of metastasis in malignant melanoma? A four-year experience report

Is increased serum S-100 protein concentration a marker of metastasis in malignant melanoma? A... Between October 1999 and October 2003, S-100 serum protein concentration was measured in 880 samples obtained from 178 consecutive patients with histologically-confirmed malignant melanoma. S-100 concentration was measured with an assay based on three monoclonal antibodies against bovine S-100 protein B-subunit, using an automated chemiluminescence analyzer (Liaison, Diasorin, Saluggia, Italy). This method is much faster (less than 1 h) than the available technology which has been employed in most of previous studies in this field, and allows the surgeon to integrate S-100 concentration levels in his decision-making about patient management and follow-up scheduling. Seventeen out of 178 patients (9.55%) had local or distant metastasis. In 14 of them (82.35%), S-100 levels were higher then 250 ng/L (decision level) when disease progression was detected. Furthermore, the follow-up for five patients showed that a renewed rise of S-100 concentration reflected a new tumor recurrence. Our results confirm that serum S-100 concentration rises with disease progression, and that increased levels are often the first symptoms of recurrence. Furthermore, the study adds to this notion the clinical gain provided by availability of S-100 values before patient evaluation. The management of patients is greatly improved, with benefit to both patient and surgeon. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Plastic Surgery Springer Journals

Is increased serum S-100 protein concentration a marker of metastasis in malignant melanoma? A four-year experience report

Loading next page...
 
/lp/springer_journal/is-increased-serum-s-100-protein-concentration-a-marker-of-metastasis-5nZAQWQ94R
Publisher
Springer-Verlag
Copyright
Copyright © 2005 by Springer-Verlag
Subject
Medicine
ISSN
0930-343X
eISSN
1435-0130
D.O.I.
10.1007/s00238-004-0696-9
Publisher site
See Article on Publisher Site

Abstract

Between October 1999 and October 2003, S-100 serum protein concentration was measured in 880 samples obtained from 178 consecutive patients with histologically-confirmed malignant melanoma. S-100 concentration was measured with an assay based on three monoclonal antibodies against bovine S-100 protein B-subunit, using an automated chemiluminescence analyzer (Liaison, Diasorin, Saluggia, Italy). This method is much faster (less than 1 h) than the available technology which has been employed in most of previous studies in this field, and allows the surgeon to integrate S-100 concentration levels in his decision-making about patient management and follow-up scheduling. Seventeen out of 178 patients (9.55%) had local or distant metastasis. In 14 of them (82.35%), S-100 levels were higher then 250 ng/L (decision level) when disease progression was detected. Furthermore, the follow-up for five patients showed that a renewed rise of S-100 concentration reflected a new tumor recurrence. Our results confirm that serum S-100 concentration rises with disease progression, and that increased levels are often the first symptoms of recurrence. Furthermore, the study adds to this notion the clinical gain provided by availability of S-100 values before patient evaluation. The management of patients is greatly improved, with benefit to both patient and surgeon.

Journal

European Journal of Plastic SurgerySpringer Journals

Published: Aug 1, 2005

References

  • Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma
    Abraha, HD; Fuller, LC; Du Vivier, AWP; Higgins, EM; Sherwood, RA
  • Cutaneous melanoma
    Koh, HK
  • Measurement of S-100 protein in human blood and cerebrospinal fluid: analytical method and preliminary clinical results
    Missler, U; Wiessmann, M
  • A soluble protein characteristic of the nervous system
    Moore, BW
  • Immunohistochemical demonstration of S-100 protein in malignant melanoma and pigmented nevus, and its diagnostic application
    Nakajima, T; Watanabe, S; Sato, Y; Kameya, T; Shimosato, Y; Ishihara, K
  • Neuropsychological function in patients with increased serum levels of protein S-100 after minor head injury
    Waterloo, K; Ingebrigtsen, T; Romner, B

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off